EXENS — Exosens SAS Income Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeLarge CapHigh Flyer

Annual income statement for Exosens SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	C2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	166	201	292	383	468
Cost of Revenue
Gross Profit	123	145	216	286	350
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	281	173	244	307	366
Operating Profit	-114	27.8	48.3	76.8	102
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-150	17.1	20.2	45.7	88.2
Provision for Income Taxes
Net Income After Taxes	-149	11.2	18.4	34.1	70.2
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-149	11.2	18.4	30.7	42.7
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-149	11.2	18.4	30.7	42.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.429	0.011	0.386	0.873	1.44
Dividends per Share